查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2067552

MRI造影劑市場規模、佔有率和趨勢分析報告：按產品、產品類型、應用、最終用途、地區和細分市場預測（2026-2033年）

MRI Contrast Media Agents Market Size, Share & Trends Analysis Report By Product, By Type, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10個工作天內

價格

MRI造影劑市場概覽

全球 MRI造影劑市場預計在 2025 年達到 23.9 億美元，預計到 2033 年將達到 43.3 億美元。

預計從 2026 年到 2033 年，該市場將以 7.15% 的複合年成長率成長。推動該市場成長的主要因素是癌症、神經系統疾病和心血管疾病等慢性疾病的日益普遍，而這些疾病的準確診斷需要先進的成像技術。

磁振造影（MRI）的非侵入性及其在軟組織影像方面的卓越能力正推動其應用日益廣泛，進一步刺激市場需求。此外，造影劑技術的進步，包括更安全、更具標靶性的配方，也促進了市場成長。

在全球範圍內，癌症、神經系統疾病和心血管疾病等慢性病的日益增多，顯著提升了對精準早期診斷影像的需求。造影造影（MRI），尤其是增強MRI，在腫瘤檢測、腦部異常評估和血管疾病診斷方面發揮至關重要的作用，且精確度極高。隨著疾病盛行率的上升，診斷、分期和治療進展監測所需的重複影像檢查也隨之增加，進一步推動了造影MRI的應用。這一趨勢直接促進了MRI造影劑市場的持續成長。

全球神經系統疾病負擔日益加重

據估計，全球超過三分之一的人在一生中的某個階段會經歷某種形式的神經或精神疾病，影響約 34 億人。

神經系統疾病是全球造成殘疾和生活品質下降的主要原因之一。

每年約有 1100 萬人死於神經系統疾病。

預計到 2030 年，患有失智症的人數將達到 7,800 萬，到 2050 年將達到 1.39 億。

腦部疾病造成的負擔比癌症和心血管疾病加起來還要重。

造影劑技術的進步顯著推動了磁振造影（MRI）造影劑市場的發展，提高了安全性和診斷準確性。大環钆造影劑和新興的非钆類對比劑的研發解決了毒性和體內滯留等問題，促進了其在臨床實踐中的廣泛應用。這些創新提高了影像清晰度，能夠更準確地檢測複雜的疾病，從而支持造影MRI的廣泛應用。例如，美國國家生物技術資訊中心（NCBI）於2026年2月發表的一篇綜述指出，MRI造影劑的進展主要集中在高弛豫钆造影劑（如钆苦烯醇、Gadoquatrane等）、錳造影劑和氧化鐵奈米顆粒上，這些都有助於提高影像品質和安全性。除了這些創新之外，標靶和新一代造影製劑的研發也在提高診斷準確性，拓展臨床應用範圍，進而推動MRI造影劑市場的成長。

此外，2026年4月，GE醫療宣布啟動錳基MRI造影劑“錳環醇”（mangacyclanol）的全球II/III期臨床試驗“LUMINA”，首例患者在梅奧診所接受治療。該臨床實驗藥物已獲得美國食品藥物管理局（FDA）的簡審類，目前正在評估其作為钆基造影劑的潛在替代方案，用於檢測中樞神經系統病變以及對成人和兒童患者進行全身成像。

通用電氣醫療集團製藥與診斷部門首席醫療官吉特·賽尼博士表示：「現有的钆基造影劑存在與體內钆滯留相關的安全隱患。而錳環醇則有望成為一種替代方案，同時保持與钆基造影劑相當的診斷性能，適用於包括體弱患者和需要多次掃描的患者在內的廣大患者群體。

「隨著影像需求的持續成長，我們正加速推進造影劑產品線的研發，以更好地滿足病患的需求，」GE醫療總裁兼執行長Peter Alduini表示。 “Mangacyclanol有望變革磁振造影市場，增強供應鏈的韌性，而這一臨床里程碑進一步鞏固了GE醫療在造影劑領域的領先地位。”

此外，先進影像技術的發展是磁振造影造影劑市場的另一個驅動力。這主要歸因於高場磁振造影系統的引入和放射科網路的擴展，導致檢查數量增加。影像能力的提升以及向非侵入性、高解析度診斷的轉變，推動了造影造影技術的廣泛應用。這一趨勢在新興市場尤為顯著，這些市場醫療基礎設施的改善正在加速先進影像服務的普及。

目錄

第1章：調查方法和範圍

第2章執行摘要

第3章：MRI造影劑市場：變數、趨勢與範圍

  • 市場譜系展望
  • 市場動態
  • MRI造影劑市場分析工具

第4章：MRI造影劑市場：產品具體估算與趨勢分析

  • 全球MRI造影劑市場：基於產品的波動分析，2025年和2033年
  • 全球MRI造影劑市場：基於產品的規模和趨勢分析，2021-2033年
    • 順磁性造影劑
    • 超順造影劑

第5章：MRI造影劑市場：按類型分類的估算與趨勢分析

  • 全球MRI造影劑市場：基於類型的波動分析，2025年和2033年
  • 全球MRI造影劑市場：按類型分類的規模和趨勢分析，2021-2033年
    • 臨床階段
    • 臨床前階段

第6章：MRI造影劑市場：按應用分類的估算與趨勢分析

  • 全球MRI造影劑市場：基於應用領域的波動分析（2025年和2033年）
  • 全球MRI造影的規模和趨勢分析（2021-2033年）
    • 消化器官系統
    • 靜脈
    • 肝膽系統
    • 神經影像學
    • 其他

第7章：MRI造影劑市場：依最終用途分類的估算與趨勢分析

  • 全球MRI造影劑市場：按最終用途分類的波動分析（2025年和2033年）
  • 全球MRI造影劑市場：按最終用途分類的規模和趨勢分析（2021-2033年）
    • 醫院
    • 影像中心

第8章：MRI造影劑市場：區域估算與趨勢分析

  • 區域儀錶板
  • 市場規模及趨勢分析，2021-2033年
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 丹麥
    • 挪威
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第9章 競爭情勢

  • 主要市場參與企業近期趨勢及影響分析
  • 公司分類
  • 企業市場占有率分析，2025 年
  • 企業熱力圖分析
  • 策略規劃
    • 業務拓展
    • 併購
    • 夥伴關係與合作
    • 新產品發布
    • 研究與開發
    • 公司簡介
    • GE Healthcare
    • BayerAG
    • Guerbet GmbH
    • Bracco Imaging Spa
    • Vitalquan, LLC
    • Miltenyi BIoTec BV &Co. Kg
    • Beijing Beilu Pharmaceutical Co., Ltd.
    • JB Pharma
Product Code: GVR-4-68039-973-0

MRI Contrast Media Agents Market Summary

The global MRI contrast media agents market size was estimated at USD 2.39 billion in 2025 and is projected to reach USD 4.33 billion by 2033, growing at a CAGR of 7.15% from 2026 to 2033. The market is primarily driven by the rising prevalence of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions, which require advanced imaging for accurate diagnosis.

The increasing adoption of MRI procedures, driven by their non-invasive nature and superior soft-tissue visualization, is further boosting demand. In addition, ongoing technological advancements in contrast agents, including safer and more targeted formulations, are supporting market growth.

The rising global burden of chronic diseases such as cancer, neurological disorders, and cardiovascular conditions are significantly increasing the demand for accurate and early diagnostic imaging. MRI procedures, particularly those using contrast agents, play a critical role in detecting tumors, assessing brain abnormalities, and evaluating vascular conditions with high precision. As disease prevalence grows, the need for repeated imaging for diagnosis, staging, and treatment monitoring further drives the utilization of contrast-enhanced MRI. This trend is directly contributing to the sustained expansion of the MRI contrast media agents market.

Rising Global Burden of Neurological Disorders

More than one in three people globally are expected to experience a neurological or psychiatric disorder during their lifetime, affecting approximately 3.4 billion individuals.

Neurological disorders are a leading cause of disability and reduced quality of life worldwide.

Around 11 million deaths each year are attributed to neurological conditions.

The number of people living with dementia is projected to reach 78 million by 2030 and 139 million by 2050.

The burden of brain-related disorders exceeds that of cancer and cardiovascular diseases combined.

Technological advancements in contrast agents are significantly driving the MRI contrast media market by improving both safety and diagnostic precision. The development of macrocyclic gadolinium-based agents and emerging non-gadolinium alternatives is addressing concerns about toxicity and retention, thereby encouraging wider clinical adoption. These innovations are enhancing image clarity and enabling more accurate detection of complex conditions, supporting increased utilization of contrast-enhanced MRI. For instance, in February 2026, a review published on NCBI highlighted that advancements in MRI contrast agents are centered on high-relaxivity gadolinium-based agents (e.g., gadopiclenol, gadoquatrane), manganese-based agents, and iron oxide nanoparticles, which improve imaging performance and safety profiles. These innovations, along with the development of targeted and next-generation contrast formulations, are enhancing diagnostic precision and expanding clinical applications, thereby driving growth in the MRI contrast media agents market.

Furthermore, in April 2026, GE HealthCare announced the initiation of its global Phase 2/3 LUMINA trial, with the first patient dosed for the manganese-based MRI contrast agent mangaciclanol at Mayo Clinic. The investigational agent, granted Fast Track designation by the U.S. Food and Drug Administration, is being evaluated as a potential alternative to gadolinium-based agents for detecting lesions across the central nervous system and whole-body imaging in adult and pediatric patients.

Dr. Jit Saini, Chief Medical Officer, Pharmaceutical Diagnostics, GE HealthCare, said, "Existing gadolinium-based contrast agents carry safety language associated with gadolinium retention. In comparison, mangaciclanol could offer an alternative for broad patient groups, including vulnerable patients and those requiring multiple scans, while still offering similar diagnostic performance. The FDA Fast Track designation recognizes the potential significance of mangaciclanol and aligns with our focus on advancing its development for patients."

"As demand for diagnostic imaging continues to rise, we continue to advance our imaging agent pipeline to better meet the needs of patients," said Peter Arduini, President and CEO, GE HealthCare. "This clinical milestone builds on GE HealthCare's leadership in contrast media, as mangaciclanol has the potential to transform the MR imaging market and strengthen the resiliency of its supply chain."

Moreover, growth in advanced diagnostic imaging is another driver of the MRI contrast media/agents market, as the installation of high-field MRI systems and the expansion of radiology networks increase scan volumes. Enhanced imaging capabilities and a shift toward non-invasive, high-resolution diagnostics are encouraging greater use of contrast-enhanced MRI. This trend is particularly strong in emerging markets, where improving healthcare infrastructure is accelerating access to advanced imaging services.

Global MRI Contrast Media Agents Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For the purpose of this study, Grand View Research has segmented the global MRI contrast media agents market report on the basis of product, type, application, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Paramagnetic Agents
  • Superparamagnetic Agents
  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical
  • Preclinical
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Gastrointestinal
  • Intravenous
  • Hepatobiliary
  • Neurological Imaging
  • Others
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Imaging Centers
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
    • 1.1.1. Product
    • 1.1.2. Type
    • 1.1.3. Application
    • 1.1.4. End Use
    • 1.1.5. Regional scope
    • 1.1.6. Estimates and forecast timeline
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
    • 1.5.1. Data for primary interviews in North America
    • 1.5.2. Data for primary interviews in Europe
    • 1.5.3. Data for primary interviews in Asia Pacific
    • 1.5.4. Data for primary interviews in Latin America
    • 1.5.5. Data for Primary interviews in MEA
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. MRI Contrast Media Agents Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Drivers Analysis
      • 3.2.1.1. Rising prevalence of chronic diseases
      • 3.2.1.2. Increasing demand for advanced diagnostic imaging
      • 3.2.1.3. Growing adoption of MRI procedures globally
      • 3.2.1.4. Technological advancements in contrast agents
    • 3.2.2. Market Restraints Analysis
      • 3.2.2.1. Stringent regulatory approval processes
      • 3.2.2.2. High cost of MRI procedures and contrast agents
    • 3.2.3. Market Opportunity Analysis
      • 3.2.3.1. Development of non-gadolinium-based contrast agents
      • 3.2.3.2. Advancements in targeted and organ-specific imaging agents
      • 3.2.3.3. Expansion in emerging markets
      • 3.2.3.4. Increasing adoption of personalized and precision medicine
    • 3.2.4. Market Challenge Analysis
      • 3.2.4.1. Safety and toxicity concerns associated with contrast agents
      • 3.2.4.2. Availability of alternative imaging modalities (CT, ultrasound)
  • 3.3. MRI Contrast Media Agents Market Analysis Tools
    • 3.3.1. Porter's Analysis
      • 3.3.1.1. Bargaining power of the suppliers
      • 3.3.1.2. Bargaining power of the buyers
      • 3.3.1.3. Threats of substitution
      • 3.3.1.4. Threats from new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal landscape

Chapter 4. MRI Contrast Media Agents Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Global MRI Contrast Media Agents Market: Product Movement Analysis, 2025 & 2033 (USD Million)
  • 4.3. Global MRI Contrast Media Agents Market Size & Trend Analysis, by Product, 2021 to 2033 (USD Million)
    • 4.3.1. Paramagnetic Agents
      • 4.3.1.1. Paramagnetic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Superparamagnetic Agents
      • 4.3.2.1. Superparamagnetic agents market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. MRI Contrast Media Agents Market: Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Global MRI Contrast Media Agents Market: Type Movement Analysis, 2025 & 2033 (USD Million)
  • 5.3. Global MRI Contrast Media Agents Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
    • 5.3.1. Clinical
      • 5.3.1.1. Clinical market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.3.2. Preclinical
      • 5.3.2.1. Preclinical market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. MRI Contrast Media Agents Market: Application Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Global MRI Contrast Media Agents Market: Application Movement Analysis, 2025 & 2033 (USD Million)
  • 6.3. Global MRI Contrast Media Agents Market Size & Trend Analysis, by Application , 2021 to 2033 (USD Million)
    • 6.3.1. Gastrointestinal
      • 6.3.1.1. Gastrointestinal market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.2. Intravenous
      • 6.3.2.1. Intravenous market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.3. Hepatobiliary
      • 6.3.3.1. Hepatobiliary market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.4. Neurological Imaging
      • 6.3.4.1. Neurological imaging market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 6.3.5. Others
      • 6.3.5.1. Others market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. MRI Contrast Media Agents Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Global MRI Contrast Media Agents Market: End Use Movement Analysis, 2025 & 2033 (USD Million)
  • 7.3. Global MRI Contrast Media Agents Market Size & Trend Analysis, by End Use 2021 to 2033 (USD Million)
    • 7.3.1. Hospitals
      • 7.3.1.1. Hospitals market revenue estimates and forecasts, 2021 - 2033 (USD Million)
    • 7.3.2. Imaging Centers
      • 7.3.2.1. Imaging centers market revenue estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. MRI Contrast Media Agents Market: Regional Estimates & Trend Analysis by Product, Type, Application , and End Use

  • 8.1. Regional Dashboard
  • 8.2. Market Size and Trend Analysis, 2021 to 2033
  • 8.3. North America
    • 8.3.1. North America MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.2. U.S.
      • 8.3.2.1. Key country dynamics
      • 8.3.2.2. Competitive scenario
      • 8.3.2.3. Regulatory framework
      • 8.3.2.4. Reimbursement scenario
      • 8.3.2.5. U.S. MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.3. Canada
      • 8.3.3.1. Key country dynamics
      • 8.3.3.2. Competitive scenario
      • 8.3.3.3. Regulatory framework
      • 8.3.3.4. Reimbursement scenario
      • 8.3.3.5. Canada MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.3.4. Mexico
      • 8.3.4.1. Key country dynamics
      • 8.3.4.2. Competitive scenario
      • 8.3.4.3. Regulatory framework
      • 8.3.4.4. Reimbursement scenario
      • 8.3.4.5. Mexico MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.4. Europe
    • 8.4.1. Europe MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.2. UK
      • 8.4.2.1. Key country dynamics
      • 8.4.2.2. Competitive scenario
      • 8.4.2.3. Regulatory framework
      • 8.4.2.4. Reimbursement scenario
      • 8.4.2.5. UK MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.3. Germany
      • 8.4.3.1. Key country dynamics
      • 8.4.3.2. Competitive scenario
      • 8.4.3.3. Regulatory framework
      • 8.4.3.4. Reimbursement scenario
      • 8.4.3.5. Germany MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.4. France
      • 8.4.4.1. Key country dynamics
      • 8.4.4.2. Competitive scenario
      • 8.4.4.3. Regulatory framework
      • 8.4.4.4. Reimbursement scenario
      • 8.4.4.5. France MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.5. Italy
      • 8.4.5.1. Key country dynamics
      • 8.4.5.2. Competitive scenario
      • 8.4.5.3. Regulatory framework
      • 8.4.5.4. Reimbursement scenario
      • 8.4.5.5. Italy MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.6. Spain
      • 8.4.6.1. Key country dynamics
      • 8.4.6.2. Competitive scenario
      • 8.4.6.3. Regulatory framework
      • 8.4.6.4. Reimbursement scenario
      • 8.4.6.5. Spain MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.7. Sweden
      • 8.4.7.1. Key country dynamics
      • 8.4.7.2. Competitive scenario
      • 8.4.7.3. Regulatory framework
      • 8.4.7.4. Reimbursement scenario
      • 8.4.7.5. Sweden MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.8. Denmark
      • 8.4.8.1. Key country dynamics
      • 8.4.8.2. Competitive scenario
      • 8.4.8.3. Regulatory framework
      • 8.4.8.4. Reimbursement scenario
      • 8.4.8.5. Denmark MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.4.9. Norway
      • 8.4.9.1. Key country dynamics
      • 8.4.9.2. Competitive scenario
      • 8.4.9.3. Regulatory framework
      • 8.4.9.4. Reimbursement scenario
      • 8.4.9.5. Norway MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.5. Asia Pacific
    • 8.5.1. Asia Pacific MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. China
      • 8.5.2.1. Key country dynamics
      • 8.5.2.2. Competitive scenario
      • 8.5.2.3. Regulatory framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. China MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Japan
      • 8.5.3.1. Key country dynamics
      • 8.5.3.2. Competitive scenario
      • 8.5.3.3. Regulatory framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Japan MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. India
      • 8.5.4.1. Key country dynamics
      • 8.5.4.2. Competitive scenario
      • 8.5.4.3. Regulatory framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. India MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. South Korea
      • 8.5.5.1. Key country dynamics
      • 8.5.5.2. Competitive scenario
      • 8.5.5.3. Regulatory framework
      • 8.5.5.4. Reimbursement scenario
      • 8.5.5.5. South Korea MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.6. Australia
      • 8.5.6.1. Key country dynamics
      • 8.5.6.2. Competitive scenario
      • 8.5.6.3. Regulatory framework
      • 8.5.6.4. Reimbursement scenario
      • 8.5.6.5. Australia MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. Thailand
      • 8.5.7.1. Key country dynamics
      • 8.5.7.2. Competitive scenario
      • 8.5.7.3. Regulatory framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. Thailand MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.6. Latin America
    • 8.6.1. Latin America MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Brazil
      • 8.6.2.1. Key country dynamics
      • 8.6.2.2. Competitive scenario
      • 8.6.2.3. Regulatory framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Brazil MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. Argentina
      • 8.6.3.1. Key country dynamics
      • 8.6.3.2. Competitive scenario
      • 8.6.3.3. Regulatory framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. Argentina MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • 8.7. Middle East and Africa
    • 8.7.1. Middle East and Africa MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. South Africa
      • 8.7.2.1. Key country dynamics
      • 8.7.2.2. Competitive scenario
      • 8.7.2.3. Regulatory framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. South Africa MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Saudi Arabia
      • 8.7.3.1. Key country dynamics
      • 8.7.3.2. Competitive scenario
      • 8.7.3.3. Regulatory framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Saudi Arabia MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.4. UAE
      • 8.7.4.1. Key country dynamics
      • 8.7.4.2. Competitive scenario
      • 8.7.4.3. Regulatory framework
      • 8.7.4.4. Reimbursement scenario
      • 8.7.4.5. UAE MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
    • 8.7.5. Kuwait
      • 8.7.5.1. Key country dynamics
      • 8.7.5.2. Competitive scenario
      • 8.7.5.3. Regulatory framework
      • 8.7.5.4. Reimbursement scenario
      • 8.7.5.5. Kuwait MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2025
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
    • 9.5.6. Company Profiles
    • 9.5.7. GE Healthcare
      • 9.5.7.1. Company overview
      • 9.5.7.2. Financial performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic initiatives
    • 9.5.8. Bayer AG
      • 9.5.8.1. Company overview
      • 9.5.8.2. Financial performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic initiatives
    • 9.5.9. Guerbet GmbH
      • 9.5.9.1. Company overview
      • 9.5.9.2. Financial performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic initiatives
    • 9.5.10. Bracco Imaging Spa
      • 9.5.10.1. Company overview
      • 9.5.10.2. Financial performance
      • 9.5.10.3. Product Benchmarking
      • 9.5.10.4. Strategic initiatives
    • 9.5.11. Vitalquan, LLC
      • 9.5.11.1. Company overview
      • 9.5.11.2. Financial performance
      • 9.5.11.3. Product Benchmarking
      • 9.5.11.4. Strategic initiatives
    • 9.5.12. Miltenyi Biotec B.V. & Co. Kg
      • 9.5.12.1. Company overview
      • 9.5.12.2. Financial performance
      • 9.5.12.3. Product Benchmarking
      • 9.5.12.4. Strategic initiatives
    • 9.5.13. Beijing Beilu Pharmaceutical Co., Ltd.
      • 9.5.13.1. Company overview
      • 9.5.13.2. Financial performance
      • 9.5.13.3. Product Benchmarking
      • 9.5.13.4. Strategic initiatives
    • 9.5.14. JB Pharma
      • 9.5.14.1. Company overview
      • 9.5.14.2. Financial performance
      • 9.5.14.3. Product Benchmarking
      • 9.5.14.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America MRI contrast media agents market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 5 North America MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 6 North America MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 7 U.S. MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 8 U.S. MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 9 U.S. MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 10 U.S. MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 11 Canada MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 12 Canada MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 13 Canada MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 14 Canada MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Mexico MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 16 Mexico MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 17 Mexico MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 18 Mexico MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Europe MRI contrast media agents market, by region, 2021 - 2033 (USD Million)
  • Table 20 Europe MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 21 Europe MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 22 Europe MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 23 Europe MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 24 Germany MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 25 Germany MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 26 Germany MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 27 Germany MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 28 UK MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 29 UK MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 30 UK MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 31 UK MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 32 France MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 33 France MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 34 France MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 35 France MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 36 Italy MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 37 Italy MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 38 Italy MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 39 Italy MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Spain MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 41 Spain MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 42 Spain MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 43 Spain MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 44 Denmark MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 45 Denmark MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 46 Denmark MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 47 Denmark MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 48 Sweden MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 49 Sweden MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 50 Sweden MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 51 Sweden MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 52 Norway MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 53 Norway MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 54 Norway MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 55 Norway MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 56 Asia Pacific MRI contrast media agents market, by region, 2021 - 2033 (USD Million)
  • Table 57 Asia Pacific MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 58 Asia Pacific MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 59 Asia Pacific MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 60 Asia Pacific MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 61 China MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 62 China MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 63 China MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 64 China MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Japan MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 66 Japan MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 67 Japan MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 68 Japan MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 69 India MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 70 India MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 71 India MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 72 India MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 73 South Korea MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 74 South Korea MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 75 South Korea MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 76 South Korea MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 77 Australia MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 78 Australia MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 79 Australia MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 80 Australia MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 81 Thailand MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 82 Thailand MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 83 Thailand MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 84 Thailand MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 85 Latin America MRI contrast media agents market, by region, 2021 - 2033 (USD Million)
  • Table 86 Latin America MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 87 Latin America MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 88 Latin America MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 89 Latin America MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 90 Brazil MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 91 Brazil MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 92 Brazil MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 93 Brazil MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 94 Argentina MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 95 Argentina MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 96 Argentina MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 97 Argentina MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 98 MEA MRI contrast media agents market, by region, 2021 - 2033 (USD Million)
  • Table 99 MEA MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 100 MEA MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 101 MEA MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 102 MEA MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 103 South Africa MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 104 South Africa MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 105 South Africa MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 106 South Africa MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 107 Saudi Arabia MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 108 Saudi Arabia MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 109 Saudi Arabia MRI contrast media agents market, by application, (USD Million)
  • Table 110 Saudi Arabia MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 111 UAE MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 112 UAE MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 113 UAE MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 114 UAE MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)
  • Table 115 Kuwait MRI contrast media agents market, by product, 2021 - 2033 (USD Million)
  • Table 116 Kuwait MRI contrast media agents market, by type, 2021 - 2033 (USD Million)
  • Table 117 Kuwait MRI contrast media agents market, by application, 2021 - 2033 (USD Million)
  • Table 118 Kuwait MRI contrast media agents market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 MRI contrast media agents market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Data analysis models
  • Fig. 5 Market formulation and validation
  • Fig. 6 Data validating & publishing
  • Fig. 7 Market snapshot
  • Fig. 8 Segment snapshot
  • Fig. 9 Competitive landscape snapshot
  • Fig. 10 MRI contrast media agents - market size and growth prospects (USD million)
  • Fig. 11 MRI contrast media agents market: Industry Value Chain Analysis
  • Fig. 12 MRI contrast media agents market: Market Dynamics
  • Fig. 13 MRI contrast media agents market: PORTER's Analysis
  • Fig. 14 MRI contrast media agents market: PESTEL Analysis
  • Fig. 15 MRI contrast media agents market share by product, 2025 & 2033 (USD Million)
  • Fig. 16 MRI contrast media agents market by product: market share, 2025 & 2033
  • Fig. 17 Paramagnetic agents market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 18 Superparamagnetic agents market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 19 MRI contrast media /agents market share by type, 2025 & 2033 (USD Million)
  • Fig. 20 MRI contrast media agents market, by type: market share, 2025 & 2033
  • Fig. 21 Clinical market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 22 Preclinical market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 23 MRI contrast media agents market share by application, 2025 & 2033 (USD Million)
  • Fig. 24 MRI contrast media agents market, by application: market share, 2025 & 2033
  • Fig. 25 Gastrointestinal market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 26 Intravenous market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 27 Hepatobiliary market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 28 Neurological imaging market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 29 Others market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 30 MRI contrast media agents market share by end use, 2025 & 2033 (USD Million)
  • Fig. 31 MRI contrast media agents market, by end use: market share, 2025 & 2033
  • Fig. 32 Hospitals market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 33 Imaging centers market estimates & forecasts, 2021 - 2033 (Revenue, USD Million)
  • Fig. 34 Regional marketplace: key takeaways
  • Fig. 35 North America MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 36 US MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Canada MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 38 Mexico MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Europe MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 40 UK MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Germany MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 France MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 43 Italy MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Spain MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 45 Sweden MRI contrast media agents market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 46 Denmark MRI contrast media agents market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 47 Norway MRI contrast media agents market estimates and forecasts, (2021 - 2033,) (USD Million)
  • Fig. 48 Asia Pacific MRI contrast media agents market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 49 China MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Japan MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 51 India MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 South Korea MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 53 Australia MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Thailand MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 55 Latin America MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Brazil MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 57 Argentina MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 MEA MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 South Africa MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 60 Saudi Arabia MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 UAE MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 62 Kuwait MRI contrast media agents market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 Key company categorization
  • Fig. 64 Company market positioning
  • Fig. 65 Key company market share analysis, 2025
  • Fig. 66 Strategic framework